In the BioHarmony Drug Report Database
Flumazenil
Romazicon (flumazenil) is a small molecule pharmaceutical. Flumazenil was first approved as Romazicon on 1991-12-20. It is used to treat drug overdose in the USA. The pharmaceutical is active against gamma-aminobutyric acid receptor subunit alpha-1, gamma-aminobutyric acid receptor subunit alpha-5, gamma-aminobutyric acid receptor subunit alpha-2, and gamma-aminobutyric acid receptor subunit alpha-3. In addition, it is known to target gamma-aminobutyric acid receptor subunit alpha-6 and gamma-aminobutyric acid receptor subunit alpha-4.
Trade Name
|
Romazicon |
|---|---|
Common Name
|
flumazenil |
ChEMBL ID
|
CHEMBL407 |
Indication
|
drug overdose |
Drug Class
|
Benzodiazepine receptor (agonists/antagonists) |
Image (chem structure or protein)